Corticotropin releasing factor antagonists
Corticotropin-releasing factor (CRF) antagonists having the formulae wherein the dashed lines, A, B, Y, Z, G, R3, R4, R5, R6, R16 and R17 are as defined in the application, and processes for preparing them. These compounds and their pharmaceutically acceptable salts are useful in the treatment disorders including CNS and stress-related disorders.
Pfizer Inc
C A A A A A C A C A C C C A C A A A A C A C C C A A A C C A A C A C A C A A A A C C A A A C C A
C07D A61P A61P A61P A61P A61P C07D A61P C07D A61K C07D C07D C07D A61P C07D A61P A61P A61P A61P C07D A61P C07D C07D C07D A61P A61P A61P C07D C07D A61P A61P C07D A61P C07D A61P C07D A61P A61P A61P A61P C07D C07D A61P A61P A61P C07D C07D A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Yuhpyng L.
Chen